Nesiritide therapy in a term neonate with renal disease

Pharmacotherapy. 2006 Feb;26(2):281-4. doi: 10.1592/phco.26.2.281.

Abstract

A term (39-wk-old) male neonate exhibited respiratory distress and anuria within 2 days of birth. The patient was diagnosed with pulmonary hypertension, polycystic kidney disease, and heart failure; his initial B-type natriuretic peptide concentration was 2460 pg/ml. After minimal response to loop diuretics, the patient was given an infusion of nesiritide 0.01 microg/kg/minute, with no loading dose. Urine output increased over 400%, and cardiac function improved. Nesiritide was titrated to 0.03 microg/kg/minute with no hypotension, decreased renal function, or adverse cardiac sequelae over the next 6 days. No subsequent changes in cardiac function occurred during the infant's stay in a progressive care unit, but he died at age 5.5 months due to sepsis. This case report demonstrates the successful first use of nesiritide therapy in a neonate with renal disease. Further studies are warranted to evaluate the safety and administration of this agent in the neonatal patient population.

Publication types

  • Case Reports

MeSH terms

  • Blood Urea Nitrogen
  • Diuretics / therapeutic use
  • Electrocardiography
  • Fatal Outcome
  • Heart Defects, Congenital / physiopathology
  • Heart Failure / complications
  • Heart Failure / congenital
  • Hemodynamics / drug effects
  • Humans
  • Hypertension, Pulmonary / complications
  • Hypertension, Pulmonary / congenital
  • Infant, Newborn
  • Male
  • Natriuretic Agents / therapeutic use*
  • Natriuretic Peptide, Brain / therapeutic use*
  • Polycystic Kidney Diseases / congenital*
  • Polycystic Kidney Diseases / drug therapy*

Substances

  • Diuretics
  • Natriuretic Agents
  • Natriuretic Peptide, Brain